Isolation of cDNAs using the YAC hybridization screen method. by Fidler, C, Boultwood, J

Chromosomal deletions in myelodysplasia. by Boultwood, J, Fidler, C

The human POP2 gene: identification, sequencing, and mapping to the critical region of the 5q- syndrome. by Fidler, C, Wainscoat, J, Boultwood, J

Telomere length in myelodysplastic syndromes. by Boultwood, J, Fidler, C, Wainscoat, J

Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B by Dakin, H, Fidler, C, Harper, C

Gene expression profiling in the myelodysplastic syndromes. by Pellagatti, A, Fidler, C, Wainscoat, J, Boultwood, J

Mutation analysis of the SPARC gene in the 5q-syndrome. by Fidler, C, Strickson, A, Boultwood, J, Waincoat, J

Adherence to deferoxamine therapy: Heeding hippocrates and osler by Watkins, F, Fidler, C, Boultwood, J, Wainscoat, J

BRCA2 gene deletion is rare in chronic lymphocytic leukemia. by Pilozzi, E, Fidler, C, Boultwood, J, Wainscoat, J

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia. by Watkins, F, Fidler, C, Boultwood, J, Wainscoat, J

Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspective. by Dakin, H, Sherman, M, Fung, S, Fidler, C, Bentley, A

Cost Effectiveness of Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B from a Canadian Public Payer Perspective. by Dakin, H, Sherman, M, Fung, S, Fidler, C, Bentley, A

Molecular characterization of the 7q deletion in myeloid disorders. by Lewis, S, Abrahamson, G, Boultwood, J, Fidler, C, Potter, A, Wainscoat, J

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q). by Fidler, C, Watkins, F, Bowen, D, Littlewood, T, Wainscoat, J, Boultwood, J

Glutathione S-transferase gene deletions in myelodysplasia. by Atoyebi, W, Kusec, R, Fidler, C, Peto, T, Boultwood, J, Wainscoat, J

Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia by Atoyebi, W, Kusec, R, Fidler, C, Peto, T, Boultwood, J, Wainscoat, J

Physical mapping of the human ATX1 homologue (HAH1) to the critical region of the 5q- syndrome within 5q32, and immediately adjacent to the SPARC gene. by Boultwood, J, Strickson, A, Jabs, E, Cheng, J, Fidler, C, Wainscoat, J

AMPLIFICATION OF MITOCHONDRIAL-DNA IN ACUTE MYELOID-LEUKEMIA by Boultwood, J, Fidler, C, Moss, P, Frodsham, P, Gale, R, Wainscoat, J

MOLECULAR MAPPING OF THE 7Q-DELETION IN MYELOID DISORDERS by Lewis, S, Boultwood, J, Fidler, C, Sheridan, H, Said, S, Buckle, V, Wainscoat, J

MOLECULAR MAPPING OF UNCHARACTERISTICALLY SMALL 5Q DELETIONS IN 2 PATIENTS WITH THE 5Q- SYNDROME - DELINEATION OF THE CRITICAL REGION ON 5Q AND IDENTIFICATION OF A 5Q- BREAKPOINT by Boultwood, J, Fidler, C, Lewis, S, Kelly, S, Sheridan, H, Littlewood, T, Buckle, V, Wainscoat, J